Isolation and Characterisation of Acetylcholinesterase Inhibitors from Aquilaria subintegra for the Treatment of Alzheimer’s Disease (AD)

Publisher： Bentham Science Publishers

E-ISSN： 1875-5828|11|2|206-214

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.11, Iss.2, 2014-02, pp. : 206-214

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The BRAINz trial: a novel approach to acetylcholinesterase-inhibitor treatment for Alzheimer’s disease

By Wilkinson David   Roughan Laura  

Future Neurology, Vol. 2, Iss. 4, 2007-07 ,pp. : 379-382

Future Medicine

Access to resources Recommend Favorite

Calpain inhibitors, a treatment for alzheimer’s disease: Position paper

By Battaglia Fortunato   Trinchese Fabrizio   Liu Shumin   Walter Sean   Nixon Ralph   Arancio Ottavio  

Journal of Molecular Neuroscience, Vol. 20, Iss. 3, 2003-08 ,pp. : 357-362

Humana Press, Inc

Access to resources Recommend Favorite

Acetylcholinesterase: A multifaceted target for structure-based drug design of anticholinesterase agents for the treatment of Alzheimer’s disease

By Greenblatt Harry   Dvir Hay   Silman Israel   Sussman Joel  

Journal of Molecular Neuroscience, Vol. 20, Iss. 3, 2003-08 ,pp. : 369-383

Humana Press, Inc

Access to resources Recommend Favorite

Antioxidant treatment in alzheimer’s disease: Current state

By Gilgun-Sherki Yossi   Melamed Eldad   Offen Daniel  

Journal of Molecular Neuroscience, Vol. 21, Iss. 1, 2003-09 ,pp. : 1-11

Humana Press, Inc

Access to resources Recommend Favorite

Immunological approach for the treatment of Alzheimer’s disease

By Solomon Beka  

Journal of Molecular Neuroscience, Vol. 20, Iss. 3, 2003-08 ,pp. : 283-286

Humana Press, Inc

Access to resources Recommend Favorite